---
figid: PMC6696851__10.1177_2040622319869116-fig8
figlink: /pmc/articles/PMC6696851/figure/fig8-2040622319869116/
number: F8
caption: Schematic diagram depicting possible mechanisms involved in the anti-fibrotic
  effect of melatonin and PAA. Renal IRI activated TGF-β signaling and caused renal
  fibrosis. Treatment with both melatonin and PAA simultaneously inhibit renal fibrosis,
  but the underlying mechanisms are totally different. Melatonin treatment targets
  multiple downstream mediators of TGF-β signaling, including Smad2, Smad3, Smad4,
  Smad7, PI3K, ERK1/2, and p38, while PAA treatment attenuates renal fibrosis by selectively
  inhibiting Smad3 phosphorylation via disturbing the interactions of Smad3 with TGFβRI
  and SARA. Interestingly, PAA treatment can enhance the inhibitory effects of melatonin
  on Smad2 and Smad3 phosphorylation. Besides, PAA has greater inhibitory effects
  than melatonin on the activation of Wnt/β-catenin signaling and downstream target
  genes.IRI, ischemia-reperfusion injury; PAA, poricoic acid A; PAI-1, plasminogen
  activator inhibitor-1; SARA, Smad anchor for receptor activation; TGF-β, transforming
  growth factor-β, TGFβRI, transforming growth factor-β receptor II.
pmcid: PMC6696851
papertitle: Combined melatonin and poricoic acid A inhibits renal fibrosis through
  modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum.
reftext: Dan-Qian Chen, et al. Ther Adv Chronic Dis. 2019;10:2040622319869116.
pmc_ranked_result_index: '124353'
pathway_score: 0.9657708
filename: 10.1177_2040622319869116-fig8.jpg
figtitle: Schematic diagram depicting possible mechanisms involved in the anti-fibrotic
  effect of melatonin and PAA
year: '2019'
organisms:
- Homo sapiens
ndex: 092cf19f-ded2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6696851__10.1177_2040622319869116-fig8.html
  '@type': Dataset
  description: Schematic diagram depicting possible mechanisms involved in the anti-fibrotic
    effect of melatonin and PAA. Renal IRI activated TGF-β signaling and caused renal
    fibrosis. Treatment with both melatonin and PAA simultaneously inhibit renal fibrosis,
    but the underlying mechanisms are totally different. Melatonin treatment targets
    multiple downstream mediators of TGF-β signaling, including Smad2, Smad3, Smad4,
    Smad7, PI3K, ERK1/2, and p38, while PAA treatment attenuates renal fibrosis by
    selectively inhibiting Smad3 phosphorylation via disturbing the interactions of
    Smad3 with TGFβRI and SARA. Interestingly, PAA treatment can enhance the inhibitory
    effects of melatonin on Smad2 and Smad3 phosphorylation. Besides, PAA has greater
    inhibitory effects than melatonin on the activation of Wnt/β-catenin signaling
    and downstream target genes.IRI, ischemia-reperfusion injury; PAA, poricoic acid
    A; PAI-1, plasminogen activator inhibitor-1; SARA, Smad anchor for receptor activation;
    TGF-β, transforming growth factor-β, TGFβRI, transforming growth factor-β receptor
    II.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD10
  - LRP6
  - FZD1
  - FZD2
  - FZD5
  - CTNNB1
  - FZD8
  - FZD9
  - LRP5
  - FZD3
  - MMP7
  - MAPK14
  - MAPK11
  - SMAD5
  - MAPK12
  - SERPINE1
  - MUC1
  - MAPK13
  - TGFB1
  - FZD7
  - SMAD2
  - SMAD3
  - SMAD4
  - SMAD6
  - SMAD7
  - SMAD9
  - SNAI1
  - FZD6
  - SMAD1
  - FZD4
  - SMN1
  - Melatonin
  - PAA
  - melatonin
  - Ischemia
genes:
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: LRP5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: •MMP-7
  symbol: MMP7
  source: hgnc_symbol
  hgnc_symbol: MMP7
  entrez: '4316'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: •PAI-1
  symbol: PAI1
  source: hgnc_prev_symbol
  hgnc_symbol: SERPINE1
  entrez: '5054'
- word: pems
  symbol: PEM
  source: hgnc_alias_symbol
  hgnc_symbol: MUC1
  entrez: '4582'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: TGF-B1
  symbol: TGFB1
  source: hgnc_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: Smad2
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Smad7
  symbol: SMAD7
  source: hgnc_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: •Snail
  symbol: SNAIL
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: Frizzled
  symbol: Frizzled
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: •SMA
  symbol: SMA
  source: hgnc_prev_symbol
  hgnc_symbol: SMN1
  entrez: '6606'
chemicals:
- word: Melatonin
  source: MESH
  identifier: D008550
- word: PAA
  source: MESH
  identifier: C067433
- word: melatonin
  source: MESH
  identifier: D008550
diseases:
- word: Ischemia
  source: MESH
  identifier: D007511
figid_alias: PMC6696851__F8
redirect_from: /figures/PMC6696851__F8
figtype: Figure
---
